Avantor Inc at Raymond James Institutional Investors Conference (Virtual) Transcript
Okay. Good afternoon, everyone, and welcome to the 42nd Annual Raymond James Institutional Investors Conference. I'm Larry Keusch, the hospital supplies analyst. I recognize that it is getting late in the day and we appreciate everybody's attention and focus, but we are really excited for our next fireside chat.
It is my distinct pleasure to welcome Avantor. Avantor is a leader in specialty chemicals, proprietary materials, high value-added services and third-party distribution to a broad array of customers, including life science and health care applications. We are joined this afternoon by Michael Stubblefield, who is President and CEO; Tom Szlosek, who is Executive Vice President and Chief Financial Officer; and Tommy Thomas, who is not visible on the screen, is there and listening, who is Vice President of Investor Relations.
So Michael, let's just start out because the one thing that characterizes the Raymond James conference is that it is a generalist conference, and so there are probably people on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
